InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018

This information was provided by prnewswire

Send your Press Release here.


VANCOUVER, Nov. 5, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will report financial results for the three months ended September 30, 2018, which is the Company’s first quarter of fiscal year 2019 (“1Q19”), on Monday, November 12, 2018.


Conference Call & Webcast:
Monday, November 12, 2018 at 10:00 AM Pacific Time, 1:00 PM Eastern Time

Toronto: +1-416-764-8688
Vancouver: +1-778-383 7413
North America (Toll Free):   +1-888-390 0546
Conference ID: 01602924

Replays, Available through November 19, 2018:

Toronto: +1-416-764-8677
North America (Toll Free): +1-888-390-0541
Playback Passcode: 602924#

The Company’s full financial statements and related MD&A for the three months ended September 30, 2018 will be available at on November 12, 2018.

Emerald contributor since March 2012


Your email address will not be published.